Search Results

There are 33969 results for: content related to: A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

  1. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 5, May 2015, Pages: 468–477, Md Jamal Uddin, Rolf H. H. Groenwold, Tjeerd P. van Staa, Anthonius de Boer, Svetlana V. Belitser, Arno W. Hoes, Kit C. B. Roes and Olaf H. Klungel

    Version of Record online : 20 NOV 2014, DOI: 10.1002/pds.3724

  2. You have free access to this content
    Prior event rate ratio adjustment: numerical studies of a statistical method to address unrecognized confounding in observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 60–68, Menggang Yu, Dawei Xie, Xingmei Wang, Mark G. Weiner and Richard L. Tannen

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3235

  3. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 636–645, James D. Lewis, Laurel Habel, Charles Quesenberry, Ronac Mamtani, Tiffany Peng, Warren B. Bilker, Monique Hedderson, Lisa Nessel, David J. Vaughn, Brian L. Strom and Assiamira Ferrara

    Version of Record online : 25 APR 2014, DOI: 10.1002/pds.3619

  4. Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors

    International Journal of Clinical Practice

    Volume 63, Issue 6, June 2009, Pages: 912–929, G. Schernthaner

    Version of Record online : 13 MAY 2009, DOI: 10.1111/j.1742-1241.2009.02025.x

  5. Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 539–547, Amarsinh M. Desai, Teresa M. Cavanaugh, Vibha C. A. Desai, Pamela C. Heaton and Christina M. L. Kelton

    Version of Record online : 12 MAR 2014, DOI: 10.1002/pds.3605

  6. Validation of a claims-based antipsychotic polypharmacy measure

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 628–635, Emily Leckman-Westin, Edith Kealey, Nitin Gupta, Qingxian Chen, Tobias Gerhard, Stephen Crystal, Mark Olfson and Molly Finnerty

    Version of Record online : 24 MAR 2014, DOI: 10.1002/pds.3609

  7. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  8. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  9. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  10. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Version of Record online : 10 MAR 2014, DOI: 10.1002/pds.3592

  11. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596

  12. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  13. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 28 JAN 2016, DOI: 10.1002/pds.3966

  14. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 10, October 2015, Pages: 1026–1035, Jason C. Hsu, Ching-Lan Cheng, Dennis Ross-Degnan, Anita K. Wagner, Fang Zhang, Yea-Huei Kao Yang, Li-Ling Liu, Hsueh-Yung Tai, Ke-Hsin Chen, Po-Wen Yang and Christine Y. Lu

    Version of Record online : 6 AUG 2015, DOI: 10.1002/pds.3834

  15. Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 12, December 2015, Pages: 1259–1270, Diogo Mendes, Carlos Alves and Francisco Batel-Marques

    Version of Record online : 16 SEP 2015, DOI: 10.1002/pds.3874

  16. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Version of Record online : 27 JAN 2014, DOI: 10.1002/pds.3566

  17. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Version of Record online : 2 NOV 2015, DOI: 10.1002/pds.3880

  18. Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue S1, October 2014, Pages: 1–497,

    Version of Record online : 30 SEP 2014, DOI: 10.1002/pds.3701

  19. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Version of Record online : 12 JUL 2013, DOI: 10.1002/pds.3480

  20. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 560–571, Shibing Yang, Charles B. Eaton, Juan Lu and Kate L. Lapane

    Version of Record online : 24 JAN 2014, DOI: 10.1002/pds.3569